Literature DB >> 20936570

Code status discussions: agreement between internal medicine residents and hospitalized patients.

Laura L Loertscher1, Thomas J Beckman, Stephen S Cha, Darcy A Reed.   

Abstract

BACKGROUND: Medical residents frequently participate in code status discussions, yet their competency in this role has not been evaluated.
PURPOSE: The objective is to determine the quality of code status discussions from the perspective of both resident and patient.
METHODS: We conducted a cross-sectional survey of consecutive pairs of hospitalized patients and admitting residents at Mayo Clinic in March 2007. We measured perceptions of occurrence and content of code status discussions, admission volume, and demographic information.
RESULTS: Among the 41 matched pairs, residents and patients agreed that a code status conversation occurred in 63% of cases. Agreement was more likely if residents performed less than 4 admissions (p= .02). Patients reported the inclusion of specific discussion components, such as resuscitation procedures (7%) and outcomes (0%), less frequently than residents (71% and 27%, respectively, p< .001).
CONCLUSIONS: Residents and patients demonstrated poor agreement on the occurrence and components of code status conversations. Residency programs should identify ways to enhance residents' competency in eliciting patients' code status preferences and provide adequate time for code status discussions.

Entities:  

Mesh:

Year:  2010        PMID: 20936570     DOI: 10.1080/10401334.2010.512537

Source DB:  PubMed          Journal:  Teach Learn Med        ISSN: 1040-1334            Impact factor:   2.414


  2 in total

1.  Making progress with code status documentation.

Authors:  Rashmi K Sharma; Anthony C Breu
Journal:  J Hosp Med       Date:  2015-04-15       Impact factor: 2.960

2.  Unpacking resident-led code status discussions: results from a mixed methods study.

Authors:  Rashmi K Sharma; Nelia Jain; Namrata Peswani; Eytan Szmuilowicz; Diane B Wayne; Kenzie A Cameron
Journal:  J Gen Intern Med       Date:  2014-02-14       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.